{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:33:42Z","timestamp":1790519622105,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3056,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jpainsymman.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T00:34:56Z","timestamp":1313886896000},"page":"e4-e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intolerance to Mirtazapine in Advanced Cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"Mellar P.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordanka","family":"Kirkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lagman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Karafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2011.05.002_bib1","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/0277-5379(89)90353-2","article-title":"Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group","volume":"25","author":"Della Cuna","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib2","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/0277-5379(89)90354-4","article-title":"Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group","volume":"25","author":"Popiela","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jpainsymman.2011.05.002_bib3","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1097\/00004714-199704001-00005","article-title":"Mirtazapine: clinical advantages in the treatment of depression","volume":"17","author":"Burrows","year":"1997","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/j.1875-9114.1997.tb03674.x","article-title":"Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects","volume":"17","author":"Stimmel","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004850-199911000-00002","article-title":"Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group","volume":"14","author":"Leinonen","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.4088\/JCP.v64n0810","article-title":"A\u00a0double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks\u2019 treatment with mirtazapine or fluoxetine in depressed Chinese patients","volume":"64","author":"Hong","year":"2003","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.jpainsymman.2011.05.002_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-199512004-00006","article-title":"Safety of mirtazapine: a review","volume":"10","author":"Montgomery","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","article-title":"Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain","volume":"48","author":"Bomholt","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-2044.2010.06561.x","article-title":"Efficacy of mirtazapine in preventing intrathecal morphine-induced nausea and vomiting after orthopaedic surgery","volume":"65","author":"Chang","year":"2010","journal-title":"Anaesthesia"},{"issue":"Suppl 3","key":"10.1016\/j.jpainsymman.2011.05.002_bib10","first-page":"10","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction","volume":"62","author":"Montejo","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2010.10.077","article-title":"The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain","volume":"651","author":"Haduch","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FPC.0b013e32833b593a","article-title":"ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression","volume":"20","author":"Sarginson","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2125.2010.03728.x","article-title":"Evaluation of a QT nomogram for risk assessment after antidepressant overdose","volume":"70","author":"Waring","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S1461145701002565","article-title":"Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression","volume":"4","author":"Bech","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.jpainsymman.2011.05.002_bib15","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0959-8049(01)00448-8","article-title":"Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer","volume":"38","author":"Fayers","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1200\/JCO.2010.30.7173","article-title":"Trajectory of performance status and symptom scores for patients with cancer during the last six months of life","volume":"29","author":"Seow","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00019442-200209000-00007","article-title":"Mirtazapine vs. Paroxetine Study Group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients","volume":"10","author":"Schatzberg","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib18","first-page":"444","article-title":"Symptom evaluation in palliative medicine: patient report vs. systematic assessment","volume":"14","author":"Homsi","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2011.05.002_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/0269216309104057","article-title":"Characteristics and implications of attrition in health-related quality of life studies in palliative care","volume":"23","author":"Ahlner-Elmqvist","year":"2009","journal-title":"Palliat Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411003204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392411003204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:06:35Z","timestamp":1760130395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392411003204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0885392411003204"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.05.002","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intolerance to Mirtazapine in Advanced Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}